Venetoclax (Venclexta)

[ ANTI-CANCER DRUGS ]
UNIT PRICE: 8,999.00 USD
  8,999.00 USD
Sold Out

trade name Venclexta/Venclyxto

Related Products

Product Details

Its a small molecule oral drug that treats chronic lymphocytic leukemia (CLL) in those with a specific chromosomal abnormality. In 2015, the United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to venetoclax for subjects with CLL who have relapsed or have been refractory to previous treatment and have the 17p deletion genetic mutation.
VIEW ALL PRODUCTS